"Your suggestions of herbs to treat cancer suggests you're a conspiracy theorist with no real knowledge of the industry"
What are you talking about, your suggesting investing in a company where their lead drug is a Herb/ Plant (EBC-46 aka Hylandia dockrillii)- which I can't find any pair reviewed studies/ journal reports to back up the company's claims. What I suggested is that if you want to go down the path of Plants/ Herbs being used in SOC cancer treatments, then you should check out "lei gong teng", which actually has pair reviewed studies posted in medical journals and on the likes of "Pub-med", thus has some creditability within the industry.
What acquisitions are you referring to? This company looks like the biggest piece of hot air I've seen for awhile. Looks at the Directors, there's not even one Biochemist directly involved, nor is there anyone with Oncology/ industry experience- just a bunch of veterinary specialists by the looks of it.
For the record there's never been an Aussie biotech that's been acquired for big $$ by a US pharma during a Phase 1/2a oncology study. In fact there's never been one acquired full stop. Let alone one that's lead compound is based off a plant found in" the tropical rainforests of North Queensland". Sounds like a patient nightmare.
Look at the likes of Alchmeia( ASX:ACL), their Market cap is around 100mil- their Oncology side has a rich pipeline with their lead compound currently in a fully funded, FDA approved global phase 3 study, with other multiple phase 2 studies running( one of them is even sponsored by big pharma). They also sell a drug( Fondaparinux) that makes them around 12 million NPAT . Yet their market cap is only 100 million, however not much more than half of that would be contributed to the Oncology side( the other to their revenue generator- Fonda). So theoretically it's valued at not much more than QBIOTICS :/
Are you currently invested in any Oncology company's? Particularly those on the ASX? Do you know what big Pharma look for when they acquire early stage company's?
I think your the one living under the rock here. This company will keep sucking investors dry for years. There's red flags all over it- go ask anyone who specializes in biotech's.
